Discover What Financial Markets Can Do For You

Credibility, Competitive Advantage, New Business

EXPLORE OUR LATEST ANALYSIS

CMA’s Veterinary Remedies Bring New Risks for Private Equity Portfolios

The Competition and Markets Authority (CMA) has concluded its extensive investigation into…

The Deutsche Börse-Allfunds Remedy Plan: Openness, Data Neutrality, and Euroclear

Deutsche Börse is playing the Savings and Investments Union (SIU) card to…

Antitrust Implications of Four Financial Red Flags in the PSKY-WBD Merger

While the headline $31-per-share cash offer is designed to appease WBD stockholders,…

A Unicredit-Commerzbank Full Takeover Wouldn’t Raise Antitrust Concerns

UniCredit has launched its latest attempt to increase its stake in Germany’s…

FINANCE FOR ANTITRUST LAWYERS

The Rise of Private Capital in Europe: Part Three

The "Deal Engine" Mindset and the Language of IRR In the first two parts of…

How to Turn a Redacted Merger Decision into a Usable Precedent

Imagine you are researching precedents for an important case and find a decision that seems…

The Compounding Effect of a Cartel: More than “Just” Higher Prices

When firms collude on price, they’re not just overcharging customers. They’re also reshaping revenue, profits,…

When Capital Injections Raise Regulatory Red Flags

A capital increase is when a company issues new shares to raise additional equity from…

Want to receive push notifications for all major on-site activities?